Journal article
Final results from the REPRISE I study: Five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
R Gooley, SG Worthley, RJ Whitbourn, J Montarello, AE Newcomb, DJ Allocco, IT Meredith
Eurointervention | EUROPA EDITION | Published : 2018
Grants
Awarded by Medtronic
Funding Acknowledgements
The REPRISE I study was sponsored and funded by Boston Scientific Corporation. ClinicalTrials. gov Identifier: NCT01383720.